During the past decade, South Carolina Nephrology and Hypertension Center, Inc. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 13 clinical trials were completed, i.e. on average, 76.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Carolina Nephrology and Hypertension Center, Inc." #1 sponsor was "Pfizer" with 4 trials, followed by "Kibow Pharma" with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Reata Pharmaceuticals, Inc." with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Carolina Nephrology and Hypertension Center, Inc." #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "South Carolina Nephrology and Hypertension Center, Inc." are "Diabetes Mellitus, Type 2" (4 trials), "Chronic Kidney Disease" (3 trials), "Alport Syndrome" (2 trials), "Chronic Kidney Disease stage4" (2 trials) and "Chronic Kidney Diseases" (2 trials). Many other conditions were trialed in "South Carolina Nephrology and Hypertension Center, Inc." in a lesser frequency.

Most popular intervention types in "South Carolina Nephrology and Hypertension Center, Inc." are "Drug" (22 trials), "Biological" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Epoetin Hospira" (2 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials) and "vildagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "South Carolina Nephrology and Hypertension Center, Inc." are 28 trials for "All" genders.

Currently, there are NaN active trials in "South Carolina Nephrology and Hypertension Center, Inc.". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in South Carolina Nephrology and Hypertension Center, Inc., 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in South Carolina Nephrology and Hypertension Center, Inc., 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".